Diabetes mellitus in long-term survivors of childhood cancer - Increased risk associated with radiation therapy: A report for the childhood cancer survivor study

Archives of Internal Medicine

Volumn 169, Issue 15, 2009, Pages 1381-1388

  Meacham, Lillian R ^a   Sklar, Charles A ^b   Li, Suwen ^c   Liu, Qi ^c   Gimpel, Nora ^d   Yasui, Yutaka ^c   Whitton, John A ^e   Stovall, Marilyn ^f   Robison, Leslie L ^g   Oeffinger, Kevin C ^b  

^a EMORY UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; CORTICOSTEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BODY MASS; BONE TUMOR; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; DIABETES MELLITUS; ETHNICITY; HEALTH INSURANCE; HODGKIN DISEASE; HUMAN; IMMOBILIZATION; INCOME; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SCHOOL CHILD; SELF CONCEPT; SELF REPORT; SIBLING; SKULL IRRADIATION; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; SURVIVAL TIME; WHOLE BODY RADIATION;

ABDOMEN; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BODY MASS INDEX; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; CRANIAL IRRADIATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEOPLASMS; ODDS RATIO; RADIATION INJURIES; RISK FACTORS; SURVIVORS; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 68849128718     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.209     Document Type: Article

References (48)

1. Oeffinger KC, Mertens AC, Sklar CA, et al; Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-1582.
2. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100(19):1368-1379.
3. Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945-950.
4. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 2007;109(4):1765-1772.
5. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol. 2004; 26(2):81-90.
6. Lorini R, Cortona L, Scaramuzza A, et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant. 1995; 15(6):873-877.
7. Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab. 2006;91(11):4401-4407.
8. Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant. 2006;37(12): 1109-1117.
9. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet. 2000;356(9234):993-997.
10. Cicognani A, Cacciari E, Mancini AF, et al. Abnormal insulin response to glucose following treatment for Wilms' tumor in childhood. Eur J Pediatr. 1997;156 (5):371-375.
11. Teinturier C, Tournade MF, Caillat-Zucman S, et al. Diabetes mellitus after abdominal radiation therapy. Lancet. 1995;346(8975):633-634.
12. Gurney JG, Ness KK, Stovall M, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88(10):4731-4739.
13. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26 (28):4639-4645.
14. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229-239.
15. Mertens AC, Walls RS, Taylor L, et al. Characteristics of childhood cancer survivors predicted their successful tracing. J Clin Epidemiol. 2004;57(9):933-944.
16. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000;283(17):2253-2259.
17. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21(4): 518-524.
18. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2003.
19. Macera CA, Ham SA, Yore MM, et al. Prevalence of physical activity in the United States: Behavioral Risk Factor Surveillance System, 2001. Prev Chronic Dis. 2005; 2(2):A17.
20. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London, England: Taylor & Francis Group; 1993.
21. Liang K, Zeger SL. Longitudinal data analysis for discrete and continuous outcomes using generalized linear models. Biometrika. 1986;73(1):13-22.
22. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107(6):1303-1312.
23. Oeffinger KC, Buchanan GR, Eshelman DA, et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2001;23(7):424-430.
24. Talvensaari KK, Lanning M, Tapanainen P, Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab. 1996;81(8):3051-3055.
25. Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35(2):91-95.
26. Mohn A, Di Marzio A, Capanna R, Fioritoni G, Chiarelli F. Persistence of impaired pancreatic beta-cell function in children treated for acute lymphoblastic leukaemia. Lancet. 2004;363(9403):127-128.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(suppl 1):S55-S60.
28. Hawkins MM, Robertson CM, Edge JA, Neil HA. Is risk of diabetes mellitus increased after abdominal radiotherapy? Lancet. 1996;347(9000):539-540.
29. Du Toit DF, Heydenrych JJ, Smit B, et al. The effect of ionizing radiation on the primate pancreas: an endocrine and morphologic study. J Surg Oncol. 1987; 34(1):43-52.
30. Sarri Y, Conill C, Verger E, Tomas C, Gomis R. Effects of single dose irradiation on pancreatic beta-cell function. Radiother Oncol. 1991;22(2):143-144.
31. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring). 2006; 14(suppl 5):242S-249S.
32. Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007;18(3):263-270.
33. Perkins JL, Kunin-Batson AS, Youngren NM, et al. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer. 2007;49(7):958-963.
34. Sklar C, Boulad F, Small T, Kernan N. Endocrine complications of pediatric stem cell transplantation. Front Biosci. 2001;6:G17-G22.
35. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982; 55(5):973-982.
36. Nilsson AG, Svensson J, Johannsson G. Management of growth hormone deficiency in adults. Growth Horm IGF Res. 2007;17(6):441-462.
37. Link K, Moell C, Garwicz S, et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 2004;89(10):5003-5012.
38. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006; 154(6):899-906.
39. Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005;174(3):827-834.
40. Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes. 2007;14(3):226-234.
41. Després JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006;38(1):52-63.
42. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39-48.
43. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab. 2006;91(11):4459-4466.
44. Arner P. Free fatty acids-do they play a central role in type 2 diabetes? Diabetes Obes Metab. 2001;3(suppl 1):11-19.
45. Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E. HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms. AIDS Res Ther. 2007;4(1):14.
46. Meacham LR, Gurney JG, Mertens AC, et al. Body mass index in long-term survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer. 2005;103(8):1730-1739.
47. Florin TA, Fryer GE, Miyoshi T, et al. Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1356-1363.
48. Ness KK, Leisenring WM, Huang S, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2009;115(9):1984-1994.